Adult T-cell leukemia: a review of epidemiological evidence
M Iwanaga, T Watanabe, K Yamaguchi - Frontiers in microbiology, 2012 - frontiersin.org
Adult T-cell leukemia (ATL) is an aggressive T-cell malignancy caused by human T-cell
leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as …
leukemia virus type I (HTLV-1) infection and often occurs in HTLV-1-endemic areas, such as …
Inflammatory manifestations of HTLV-1 and their therapeutic options
F Martin, GP Taylor, S Jacobson - Expert review of clinical …, 2014 - Taylor & Francis
Human T lymphotropic virus type 1 (HTLV-1) is one of the most intriguing retroviruses
infecting humans. Most commonly, infection remains undetected, since it does not cause …
infecting humans. Most commonly, infection remains undetected, since it does not cause …
Current prevalence of HTLV‐1 in Japan as determined by screening of blood donors
M Satake, K Yamaguchi… - Journal of medical …, 2012 - Wiley Online Library
The human T-lymphotropic virus type 1 (HTLV-1; Retroviridae, Deltaretrovirus, Simian T
lymphotropic virus) is a pathogenic retrovirus that causes adult T-cell leukemia, HTLV-1 …
lymphotropic virus) is a pathogenic retrovirus that causes adult T-cell leukemia, HTLV-1 …
HTLV-1 extracellular vesicles promote cell-to-cell contact
DO Pinto, C DeMarino, ML Pleet, M Cowen… - Frontiers in …, 2019 - frontiersin.org
Human T-cell leukemia virus-1 (HTLV-1) is a neglected and incurable retrovirus estimated to
infect 5 to 10 million worldwide. Specific indigenous Australian populations report infection …
infect 5 to 10 million worldwide. Specific indigenous Australian populations report infection …
Prevalence of human T-lymphotropic virus type 1 and 2 (HTLV-1/-2) infection in pregnant women in Brazil: a systematic review and meta-analysis
Human T-lymphotropic virus type 1 (HTLV-1) infection may cause serious disease, while
pathogenicity of HTLV-2 is less certain. There are no screening or surveillance programs for …
pathogenicity of HTLV-2 is less certain. There are no screening or surveillance programs for …
Human T-cell lymphotropic virus type-1: a lifelong persistent infection, yet never truly silent
A Hirons, G Khoury, DFJ Purcell - The Lancet Infectious Diseases, 2021 - thelancet.com
Human T-cell lymphotropic virus type-1 (HTLV-1) has a large global burden and in some key
communities, such as Indigenous Australians living in remote areas, greater than 45% of …
communities, such as Indigenous Australians living in remote areas, greater than 45% of …
Mother-to-child transmission of human T-cell lymphotropic viruses-1/2: what we know, and what are the gaps in understanding and preventing this route of infection
ABF Carneiro-Proietti… - Journal of the …, 2014 - academic.oup.com
Although human T-cell lymphotropic viruses (HTLV-1/2) were described over 30 years ago,
they are relatively unknown to the public and even to healthcare personnel. Although HTLV …
they are relatively unknown to the public and even to healthcare personnel. Although HTLV …
Lower prevalence of anti‐HTLV‐1 as expected by previous models among first‐time blood donors in Japan
M Satake, Y Sagara, I Hamaguchi - Journal of Medical Virology, 2023 - Wiley Online Library
An estimated 1.08 million carriers of human T‐lymphotropic virus 1 (HTLV‐1) were living in
Japan in 2006–2007. Since that study, new data on horizontal infection, nationwide …
Japan in 2006–2007. Since that study, new data on horizontal infection, nationwide …
HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
N Tardiota, N Jaberolansar, JA Lackenby, KJ Chappell… - Virology Journal, 2024 - Springer
The human T-lymphotropic virus type 1 (HTLV-1) infects millions of people globally and is
endemic to various resource-limited regions. Infections persist for life and are associated …
endemic to various resource-limited regions. Infections persist for life and are associated …
Cancer risk at low doses of ionizing radiation: artificial neural networks inference from atomic bomb survivors
MS Sasaki, A Tachibana… - Journal of radiation …, 2014 - academic.oup.com
Cancer risk at low doses of ionizing radiation remains poorly defined because of ambiguity
in the quantitative link to doses below 0.2 Sv in atomic bomb survivors in Hiroshima and …
in the quantitative link to doses below 0.2 Sv in atomic bomb survivors in Hiroshima and …